Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye - Wikidata - wikimedia - TriplyDB

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

http://www.wikidata.org/entity/Q30519895

about

Advances in drug delivery to the posterior segment Nanomedicine in the application of uveal melanoma Exciting directions in glaucoma In vivo high-frequency contrast-enhanced ultrasonography of choroidal melanoma in rabbits: imaging features and histopathologic correlations.Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye Ocular delivery of macromolecules Single compartment drug delivery.Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization.Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries.Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection Thickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations.Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles Drug and gene delivery to the back of the eye: from bench to bedside.Drug delivery techniques for treating age-related macular degeneration.Dendrimers for gene delivery--a potential approach for ocular therapy?Neurotrophin family members as neuroprotectants in retinal degenerations.MEMS: Enabled Drug Delivery Systems.Recent developments in ocular drug delivery.Delivery of steroids into the eye for the treatment of macular edema.Therapeutic Options for Retinoblastoma.Minimally invasive microneedles for ocular drug delivery.Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization.Drug delivery to the eye: what benefits do nanocarriers offer?Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage.The suprachoroidal space: from potential space to a space with potential.Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.Choroidal Changes after Suprachoroidal Injection of Triamcinolone in Eyes with Macular Edema Secondary to Retinal Vein Occlusion.Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.Ocular Drug Delivery.Neuroprotective strategies for retinal disease.Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.Imaging Suprachoroidal Layer in Exudative Age-Related Macular Degeneration.

P2860

Q26995920-D8338B03-3354-4EDD-9CEA-5D059737C4D0 Q28079572-D7F3406A-A5A5-42D9-ACCA-28AC1B1656B1 Q28542397-CF4612EE-1F02-4E59-89F1-F1F5201EA3BA Q30435544-32B396F0-3B8A-4803-A6F5-D53E610CD5F4 Q34052958-DEAB4637-FDFC-4840-8370-3314632AB353 Q34079676-494EA63C-78CC-4909-AD77-9DAA2CD47D01 Q34263907-B62EECFF-109E-45E9-A204-D7E7AF104292 Q34511156-796C23F9-C1B0-4F39-9ADA-CF4D466C3EC2 Q34511234-3DDD969D-71C4-49E4-9793-454AA4F40A90 Q35043903-802A6923-C66C-4790-8C78-86C40AA6BCF3 Q36157157-C58006BA-771F-473C-85E4-F7F58E889E7E Q36788792-29527DDC-35F9-411F-8667-3A34BAD2B979 Q36828342-587F58AA-EEDE-45E0-9763-353E1688A5B5 Q37616184-C9E53149-F958-4414-8592-601F8FA9B5D7 Q37616194-EE99ADC9-8727-4737-A734-997BB3D20010 Q37730738-96AB92E3-377C-4A27-9135-F832B764B2A7 Q37731899-55CF4BA7-C744-4345-8416-F87B196C98AE Q38161953-14A496CA-D41A-49B5-B3E5-9C99BDED29A0 Q38196447-8CA9C327-DDBC-4043-8297-B973AC779867 Q38269424-7FA94BA3-DB89-480A-A024-63E496CE490A Q38363665-0E4A33BD-073F-4C5C-B0DB-E0BA3F7D1DEA Q38603354-748028AD-581B-4186-88B7-C4B43093158D Q38815223-BE4C35A1-7A47-4967-9F1F-DC1F64824537 Q38842907-0379A876-A3E6-45F6-BA23-20287ACAEBE4 Q38916649-55EB83D7-41DA-4C11-A915-82BFC05AEA08 Q38987118-F3569D20-F10D-4797-A7F3-D13F1552C4E6 Q39076235-A4B9D295-763F-454E-8DA2-12AB0A8578B3 Q39130097-E9C70B7C-E060-43B7-A5E5-07B2E66FC2AC Q39289999-DE547992-9AA2-4193-9A3F-9241A7BC820B Q41113194-4E60AD91-6615-4095-B87B-DC79E981B2DB Q41873275-48082981-7D25-4052-B713-ABB1B7928632 Q42106768-EC464ECE-0E4E-4746-85B3-1FDD488AB910 Q45875451-AB85B95E-6DC1-4233-99B3-DC92113C1B6A Q46175825-2024460C-781C-4A13-9044-7E0805C68CC8 Q46268392-D5AD1A98-517B-400D-BE6D-7C2C3F8D11AF Q47729137-0F0BC0B4-3EE8-40E7-96A8-3A2B4DB9E781 Q51122641-FEDA6CC3-E20D-49A2-9CD5-A85A93EBA7B2 Q52372755-443E836B-F1C5-4E1A-83D3-BD298EC221B7 Q52673868-B8FD8D4E-55A7-480F-BF43-78336428BB80 Q52991700-E1301C64-D092-4B38-AEED-D2D5E6D56DF8

P2860

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

http://www.wikidata.org/entity/Q30519895

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Targeted administration into t ...... e posterior segment of the eye

@ast

Targeted administration into t ...... e posterior segment of the eye

@en

type

label

Targeted administration into t ...... e posterior segment of the eye

@ast

Targeted administration into t ...... e posterior segment of the eye

@en

prefLabel

Targeted administration into t ...... e posterior segment of the eye

@ast

Targeted administration into t ...... e posterior segment of the eye

@en

P1433

Q30519895-1417C748-A9A1-47DB-960B-C3FD6F76F15E

P1476

Q30519895-F4B0BB3C-0357-4C82-867E-021C22F072F9

P2093

Q30519895-1A6E23B0-B827-496B-9A4A-7831F52B66E7

Q30519895-45C5C43D-ED59-44BD-8350-94434E994ECD

Q30519895-501D8FA7-BF90-4D93-924A-A23080A23518

Q30519895-775A9E52-6612-4BB4-B169-8845B97B95FF

Q30519895-7AB2EEB9-0C4B-4797-8962-00B09BF0E475

Q30519895-88AEB865-15ED-4E5A-A4A1-1037CC74C2FB

P2860

Q30519895-040D9DD3-DA43-4D1D-9201-59468E47843F

Q30519895-0EB2F6A1-EF2D-4B70-9D20-2C20878F605B

Q30519895-27462426-E18D-4761-89DD-B7BC62F3C8FF

Q30519895-2BC23C69-29EF-4B29-8043-1A3E03CE1B0F

Q30519895-2C37A7DF-9D88-4C8F-89F9-06F98960A3BC

Q30519895-3D02B4C1-6411-4C05-9C1C-7941F2FACFF5

Q30519895-46D0946D-3838-475A-8357-AFB9DA78F44B

Q30519895-490FCE74-6574-4917-9555-CD87262F5C97

Q30519895-4A53D570-2DA8-412E-8D22-FF7C1BBCAFDA

Q30519895-552A2CA7-A0C0-424A-AFCE-798AB741A025

P304

Q30519895-18359268-13BB-414F-9DD1-9C0697B75CBD

P31

Q30519895-2D1FE84D-E486-42F4-A76A-7EB0765D83F5

P356

Q30519895-5761C1BB-BC49-4419-BC2D-D67605BE50A6

P407

Q30519895-F6F60788-BC55-40B1-9D4F-35B9AD320768

P433

Q30519895-58CE1485-7D17-4402-8460-B29B7866B5A2

P478

Q30519895-B7059A71-DA36-4673-A67C-AA5E851439EE

P577

Q30519895-6C4378F6-EAF8-45FE-9B10-7DFAB3D41017

P5875

Q30519895-27306463-0B9E-49EC-857F-3835957C0914

P698

Q30519895-93830CD5-6E8B-4B52-8AFD-5CCCF5685B5D

P921

Q30519895-D32E3FA8-62D3-44A9-9445-B0404E5ACE20

P932

Q30519895-A5B3E24E-616B-4486-9942-6B1F265124BF

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Targeted administration into t ...... e posterior segment of the eye

@en

P2093

Bernard E McCarey

http://www.w3.org/2001/XMLSchema#string

Damian E Berezovsky

http://www.w3.org/2001/XMLSchema#string

Henry F Edelhauser

http://www.w3.org/2001/XMLSchema#string

Mark R Prausnitz

http://www.w3.org/2001/XMLSchema#string

Samirkumar R Patel

http://www.w3.org/2001/XMLSchema#string

Vladimir Zarnitsyn

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of age-related macular degeneration in the United States

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment.

Intrascleral drug delivery to the eye using hollow microneedles.

Suprachoroidal drug delivery to the back of the eye using hollow microneedles

Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model.

Neovascular age-related macular degeneration: potential therapies.

Intravitreal injection of therapeutic agents.

Biodegradable intraocular therapies for retinal disorders: progress to date.

Medical devices for the treatment of eye diseases.

Biodegradable implants for sustained drug release in the eye.

P304

4433-4441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.12-9872

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225273127

http://www.w3.org/2001/XMLSchema#string

P698

22669719

http://www.w3.org/2001/XMLSchema#string

P921

P932

3394664

http://www.w3.org/2001/XMLSchema#string